BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18536596)

  • 1. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
    Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG
    Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation.
    Zeimer MB; Krömer I; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2010 Sep; 30(8):1282-93. PubMed ID: 20671587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2.
    Charbel Issa P; van der Veen RL; Stijfs A; Holz FG; Scholl HP; Berendschot TT
    Exp Eye Res; 2009 Jun; 89(1):25-31. PubMed ID: 19233170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations.
    Zeimer MB; Padge B; Heimes B; Pauleikhoff D
    Retina; 2010 Apr; 30(4):586-95. PubMed ID: 20386096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Berendschot TT; Staurenghi G; Holz FG; Scholl HP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1172-7. PubMed ID: 18326746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated clinical evaluation of Type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Bottoni F; Eandi CM; Pedenovi S; Staurenghi G
    Retina; 2010 Feb; 30(2):317-26. PubMed ID: 19881399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular pigment optical density in central serous chorioretinopathy.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Rohrschneider K; Holz FG; Scholl HP
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3788-95. PubMed ID: 17652753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular pigment shows ringlike structures.
    Berendschot TT; van Norren D
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):709-14. PubMed ID: 16431971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of macular pigment optical density using two different heterochromatic flicker photometers.
    Loane E; Stack J; Beatty S; Nolan JM
    Curr Eye Res; 2007 Jun; 32(6):555-64. PubMed ID: 17612971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
    Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
    Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
    Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
    Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography characteristics of group 2A idiopathic parafoveal telangiectasis.
    Sanchez JG; Garcia RA; Wu L; Berrocal MH; Graue-Wiechers F; Rodriguez FJ; Robledo V; Lizana C; Piskulich Z; Mendoza AJ; Velez-Vazquez W; Arevalo JF
    Retina; 2007; 27(9):1214-20. PubMed ID: 18046227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal vascular caliber and macular telangiectasia type 2.
    Tikellis G; Gillies MC; Guymer RH; McAllister IL; Shaw JE; Wong TY
    Ophthalmology; 2009 Feb; 116(2):319-23. PubMed ID: 19187824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Scholl HP; Gaudric A; Massin P; Kreiger AE; Schwartz S; Holz FG
    Eye (Lond); 2009 Feb; 23(2):435-41. PubMed ID: 18259211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
    Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
    Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.